Phreesia, Inc. (NYSE:PHR) SVP Sells $21,240.00 in Stock

Phreesia, Inc. (NYSE:PHR) SVP David Linetsky sold 720 shares of Phreesia stock in a transaction dated Wednesday, February 5th. The stock was sold at an average price of $29.50, for a total transaction of $21,240.00. Following the sale, the senior vice president now owns 230,051 shares of the company’s stock, valued at approximately $6,786,504.50. This trade represents a 0.31 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

David Linetsky also recently made the following trade(s):

• On Wednesday, January 29th, David Linetsky sold 500 shares of Phreesia stock. The shares were sold at an average price of $29.68, for a total transaction of $14,840.00.
• On Monday, January 27th, David Linetsky sold 11,685 shares of Phreesia stock. The shares were sold at an average price of $27.48, for a total transaction of $321,103.80.
• On Wednesday, December 18th, David Linetsky sold 24 shares of Phreesia stock. The shares were sold at an average price of $25.38, for a total transaction of $609.12.
• On Monday, December 16th, David Linetsky sold 35 shares of Phreesia stock. The shares were sold at an average price of $24.88, for a total transaction of $870.80.
• On Wednesday, December 11th, David Linetsky sold 11,853 shares of Phreesia stock. The shares were sold at an average price of $24.85, for a total transaction of $294,547.05.

Phreesia Stock Performance

PHR stock traded up $0.07 during trading on Friday, hitting $28.98. 251,586 shares of the company’s stock traded hands, compared to its average volume of 375,195. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.04. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $29.90. The stock has a fifty day moving average price of $25.82 and a two-hundred day moving average price of $23.46. The stock has a market capitalization of $1.68 billion, a price-to-earnings ratio of -19.71 and a beta of 0.96.

Phreesia (NYSE:PHR) last released its quarterly earnings data on Monday, December 9th. The company reported ($0.25) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.04. Phreesia had a negative net margin of 20.43% and a negative return on equity of 32.78%. The business had revenue of $106.80 million for the quarter, compared to analysts’ expectations of $106.33 million. During the same quarter last year, the company earned ($0.58) EPS. The company’s revenue for the quarter was up 16.6% compared to the same quarter last year. As a group, equities analysts anticipate that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. JMP Securities restated a “market outperform” rating and issued a $30.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Citigroup lifted their price target on shares of Phreesia from $31.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, January 10th. Royal Bank of Canada raised shares of Phreesia from a “sector perform” rating to an “outperform” rating and lifted their price target for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. Piper Sandler reissued an “overweight” rating and set a $33.00 target price (up from $31.00) on shares of Phreesia in a research report on Wednesday, January 29th. Finally, Truist Financial boosted their target price on shares of Phreesia from $31.00 to $34.00 and gave the stock a “buy” rating in a research report on Wednesday, December 11th. Thirteen analysts have rated the stock with a buy rating, According to MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $31.15.

Institutional Trading of Phreesia

A number of large investors have recently modified their holdings of PHR. SG Americas Securities LLC acquired a new stake in shares of Phreesia in the 3rd quarter worth about $954,000. Diversified Trust Co increased its holdings in shares of Phreesia by 12.9% in the 3rd quarter. Diversified Trust Co now owns 24,356 shares of the company’s stock worth $555,000 after acquiring an additional 2,782 shares during the period. Inspire Investing LLC acquired a new stake in shares of Phreesia in the 3rd quarter worth about $416,000. Essex Investment Management Co. LLC increased its holdings in shares of Phreesia by 44.7% in the 3rd quarter. Essex Investment Management Co. LLC now owns 117,849 shares of the company’s stock worth $2,686,000 after acquiring an additional 36,406 shares during the period. Finally, Wesbanco Bank Inc. acquired a new position in Phreesia during the 3rd quarter valued at about $593,000. Institutional investors and hedge funds own 92.10% of the company’s stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.